We will get them..... TORONTO, Jan. 25, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“GLH” or the “Company”) (CSE:GLH) (GLDFF), a leading cannabis oil solutions company built around recognized brands, today announced that its subsdiary, Medical Marijuana Group (“MMG”), recently received its first shipment of genetics at its St. Thomas, Ontario facility, marking the production facility’s transition to a functioning and plant-growing unit.
GLH’s leadership team oversaw the arrival of the first plants at the facility, which have acclimated well and are expected to be ready for cultivation in three months. The Company anticipates additional shipments in order to maintain a steady product flow once the “mothers” are ready. MMG has concurrent applications for oil extraction and wholesale licenses submitted to Health Canada and expects to receive its sales license by May.
“We are excited to have achieved this key milestone so soon after receiving MMG’s cultivation license during the fourth quarter of 2017. We believe that the quality and technology of the production facility are unlike anything currently available in the U.S. and that the on-site control mechanisms that are designed to affect almost every aspect of the grow will ensure production of high-quality product,” commented William Simpson, CEO of the Company. “MMG Canada has bold expansion plans for 2018 as it prepares for the commencement of adult-use market sales in Canada in mid-2018, and to adequately address the ever-increasing medical segment opportunity.”
MMG's genetic portfolio includes a strain that holds the highest CBD concentrations in Canada. MMG President, Phillip Millar, added, "This genetic is extremely valuable in the medical market and also holds tremendous potential for European export. We are encouraged by the strong demand for our high-quality THC strains that we expect will provide a strong platform for dynamic growth across Canada.”
To be added to the distribution list please email GLH@kcsa.com with “GLH” in the subject line.